Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer



About Anand Shah

Anand Shah is a cofounder of Ola Electric.

Anand Shah Headquarter Location



Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Anand Shah News

09:00 ET Hero Welcomes Former FDA Deputy Commissioner Anand Shah to Its Board of Directors

Jan 4, 2022

Shah joins the Board of Directors as Hero advances real-world evidence for drug development, commercialization, and post-market surveillance News provided by Share this article Share this article NEW YORK, Jan. 4, 2022 /PRNewswire/ --  Hero , the market leader for digital in-home medication management, has added a new member to the company's Board of Directors, Dr. Anand Shah, former Food and Drug Administration (FDA) Deputy Commissioner for Medical and Scientific Affairs. Dr. Shah's national leadership experience at the intersection of life sciences and healthcare delivery will accelerate Hero's mission to revolutionize care in the home. HERO's Board of Directors member As part of his role with Hero's Board of Directors, Dr. Shah will leverage his clinical experience as an oncologist and leadership in value-based care to build clinical product, partnership and policy functions at Hero in support of the company's objectives to transform how care is continuously and efficiently delivered in the home. "Dr. Shah is a timely and critical addition to our Board and a highly engaged member of the Hero team," said Kal Vepuri, CEO and founder of Hero. "He is a unique and versatile leader with a depth and breadth of experiences, policy expertise and keen intuition for what the future of our healthcare system could be. His leadership within Hero will further enable us to deliver the greatest impact for patients." "Improving medication adherence is a public health priority that is critical to improving chronic disease outcomes and reducing health care costs," said Dr. Shah. "By bringing modern, novel health-focused user experiences into the home and leveraging real-time, longitudinal data, Hero's platform brings efficiency, accessibility and quality to in-home care. This is a unique opportunity to work closely with the Board and company leadership to further this mission." From 2016 to 2021, Dr. Shah served in multiple senior leadership roles at FDA and the Centers for Medicare & Medicaid Services. During his tenure, he led the development of numerous critical healthcare policies that brought new technologies to market and expanded competition and consumer choice. Dr. Shah championed the use of real-world evidence for medical product development and in the post-market setting. As the leading digital in-home care platform delivering the first end-to-end medication management service for patients and caregivers, Hero simplifies complex medication routines, improves patient safety, and provides the measurable infrastructure necessary for optimizing value-based care. Hero's platform automatically manages medications according to an individual's unique schedule. Hero continually monitors the patient's medication inventory, facilitates continuous medication reconciliation and synchronization, and provides real-time patient-level quality measures to providers and payers. About Hero Hero is a leading digital in-home care platform delivering the first end-to-end medication management service for individuals and caregivers. Hero's solution includes its award-winning smart pill dispenser, medication management app, automatic refills, and live support. Since launching in 2018, Hero has dispensed more than 70 million medications. Hero is used as a care management solution by individuals, caregivers, medical providers, payers, and other healthcare stakeholders. SOURCE HERO

Anand Shah Investments

2 Investments

Anand Shah has made 2 investments. Their latest investment was in OneCare as part of their Seed VC on November 11, 2021.

CBI Logo

Anand Shah Investments Activity

investments chart

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.